China May Not Cut Prices Of Four Kinds Of Drugs In Next Round
This article was originally published in PharmAsia News
Executive Summary
China’s 28th round of mandatory price cuts will affect 216 varieties of drugs and may not lower the prices of the focused anti-tumor, immunological, and digestive drugs and medical blood products all at once.